CINECA IRIS Institutional Research Information System

CECCHI, Irene
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.327
EU - Europa 2.223
AS - Asia 1.159
SA - Sud America 230
AF - Africa 32
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.102
IT - Italia 658
CN - Cina 601
ES - Italia 287
IE - Irlanda 224
DE - Germania 202
JP - Giappone 166
GB - Regno Unito 148
FR - Francia 135
SE - Svezia 107
CA - Canada 105
MX - Messico 103
IN - India 77
BR - Brasile 76
VN - Vietnam 60
NL - Olanda 59
AR - Argentina 57
UA - Ucraina 47
PL - Polonia 45
CO - Colombia 44
RO - Romania 38
HK - Hong Kong 37
RU - Federazione Russa 35
FI - Finlandia 34
PT - Portogallo 33
SG - Singapore 32
TW - Taiwan 29
AU - Australia 28
BE - Belgio 28
TR - Turchia 26
GR - Grecia 25
KR - Corea 25
CH - Svizzera 23
IL - Israele 22
IR - Iran 22
AT - Austria 18
DK - Danimarca 18
CL - Cile 14
EC - Ecuador 14
PE - Perù 14
PH - Filippine 13
EG - Egitto 12
RS - Serbia 11
TH - Thailandia 10
HU - Ungheria 9
SA - Arabia Saudita 9
MA - Marocco 8
NO - Norvegia 8
SI - Slovenia 7
CR - Costa Rica 6
DZ - Algeria 6
EU - Europa 6
MY - Malesia 6
CZ - Repubblica Ceca 5
VE - Venezuela 5
BG - Bulgaria 4
BO - Bolivia 4
HR - Croazia 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
IQ - Iraq 3
MO - Macao, regione amministrativa speciale della Cina 3
PK - Pakistan 3
AM - Armenia 2
DO - Repubblica Dominicana 2
JE - Jersey 2
JO - Giordania 2
LK - Sri Lanka 2
LV - Lettonia 2
TN - Tunisia 2
UZ - Uzbekistan 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
ET - Etiopia 1
GT - Guatemala 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
SC - Seychelles 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 7.006
Salva come PNG Salva come JPEG
Città #
Chandler 389
Ann Arbor 251
Fairfield 234
Dublin 222
Redwood City 217
Beijing 163
Torino 162
Ashburn 152
Turin 128
Woodbridge 107
Wilmington 106
Houston 98
Cambridge 77
Medford 68
Seattle 68
Nyköping 66
Munich 61
Princeton 60
New York 50
Shanghai 47
Madrid 45
Montréal 44
Tokyo 43
Dearborn 38
Dong Ket 38
Rome 34
Milan 31
Hangzhou 30
Mexico City 30
San Diego 30
Córdoba 29
Paris 29
Jacksonville 26
Barcelona 24
Mcallen 24
Boston 22
Helsinki 22
Pisa 22
Chicago 21
Singapore 21
Wuhan 19
Buenos Aires 18
Guangzhou 18
Hebei 18
Los Angeles 18
Athens 17
Brussels 17
Nanjing 16
São Paulo 16
Berlin 15
Lisbon 15
Mumbai 15
Taipei 15
Warsaw 15
Chengdu 14
Guiyang 14
Medellín 14
Munro 14
Villeurbanne 14
Zhengzhou 14
Amsterdam 13
Birmingham 13
Hong Kong 13
London 12
Santiago 12
Sevilla 12
Washington 12
Falls Church 11
Hyderabad 11
Mexico 11
Ottawa 11
Santander 11
Seoul 11
Toronto 11
Valencia 11
Changsha 10
Cuenca 10
Hefei 10
Lima 10
San Francisco 10
Shenyang 10
Bogotá 9
Central District 9
Delhi 9
Kunming 9
Norwalk 9
Seville 9
Bucharest 8
Cuauhtémoc 8
Fuzhou 8
Guadalajara 8
Padova 8
San Jose 8
Shenzhen 8
Utrecht 8
Vienna 8
Belgrade 7
Brisbane 7
Jinan 7
Kansas City 7
Totale 4.034
Salva come PNG Salva come JPEG
Nome #
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome 555
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 487
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence 480
Pregnancy outcomes in mixed connective tissue disease: a multicentre study 371
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: A pooled analysis 354
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 320
The risk of ischaemic stroke in primary APS patients: a prospective study 291
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 236
Treatment of antiphospholipid syndrome 219
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome 203
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 192
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 179
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score 157
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 141
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets 137
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis 121
Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome 113
Prevalence and Thrombotic Risk Assessment of Anti-beta(2) Glycoprotein I Domain I Antibodies: A Systematic Review 112
Antiphospholipid antibodies negativization: Time for testing for non-criteria aPL? 111
Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: A randomized, placebo-controlled trial 104
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 99
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 89
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 85
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 83
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 82
Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion 77
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 76
Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study 75
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 74
IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients 73
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 73
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology 72
Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS) 70
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 67
The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience 65
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 61
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 59
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome 55
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation 55
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 54
ASIA Syndrome Following Breast Implant Placement 53
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets 53
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 52
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome 52
Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients 50
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study 48
A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response 48
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 44
Endothelial dysfunction and cardiovascular risk in lupus nephritis: new roles for old players? 40
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies 34
Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients 33
Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome 31
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach 31
Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/ prothrombin antibodies 30
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome 26
Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients 24
The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes 24
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol 23
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 23
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 22
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study 22
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience 20
Renal Fibrosis in Lupus Nephritis 17
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review 16
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App 15
Serum Biomarkers of Renal Fibrosis: A Systematic Review 14
Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues 12
Daratumumab monotherapy for refractory lupus nephritis 11
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 11
New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing 9
Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies 5
2023 ACR/EULAR classification criteria in existing research cohorts: an international study 4
Thrombosis and APS: Lessons Learned from Another Black Swan Tale 3
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology 3
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 3
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain 2
Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease 2
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review 2
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab 2
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022) 1
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases 1
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence 1
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies 1
Totale 7.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019158 0 0 0 0 0 0 0 0 0 0 88 70
2019/20201.138 52 45 58 109 91 105 138 110 132 102 115 81
2020/20211.237 98 83 149 144 133 74 76 68 95 114 78 125
2021/20221.426 83 111 110 111 155 118 114 93 100 81 158 192
2022/20231.713 153 146 90 121 146 342 125 141 160 70 123 96
2023/20241.271 156 159 130 99 151 134 118 124 44 136 20 0
Totale 7.245